Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
暂无分享,去创建一个
P Verlicchi | M Al Aukidy | D Barceló | D. Barceló | P. Verlicchi | A. Galletti | M. Petrovíc | M. Al Aukidy | M. A. Aukidy | M Petrovic | A Galletti | Damià Barceló
[1] S. Sharma,et al. Wastewater Reuse and Management , 2013 .
[2] E. C. Vasconcelos,et al. Environmental risk assessment of antibiotics: an intensive care unit analysis. , 2009, Chemosphere.
[3] Isabel Martí,et al. Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. , 2008, The Science of the total environment.
[4] Gang Yu,et al. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. , 2010, Water research.
[5] G Keck,et al. Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network. , 2005, Journal of hazardous materials.
[6] J. Hawkshead. Hospital Wastewater Containing Pharmaceutically Active Compounds and Drug-Resistant Organisms: A Source of Environmental Toxicity and Increased Antibiotic Resistance , 2008 .
[7] Thomas Heberer,et al. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements. , 2005, Journal of hazardous materials.
[8] D. Barceló,et al. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. , 2009, Analytical chemistry.
[9] Walter Giger,et al. Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. , 2002, Environmental science & technology.
[10] J. Lazorchak,et al. Risks to aquatic organisms posed by human pharmaceutical use. , 2008, The Science of the total environment.
[11] Richard M. Dinsdale,et al. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.
[12] D. Grandjean,et al. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. , 2005, Water research.
[13] A. Pollio,et al. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. , 2003, Ecotoxicology and environmental safety.
[14] P. Verlicchi,et al. Hospital Wastewaters: Quali-Quantitative Characterization and for Strategies for Their Treatment and Disposal , 2013 .
[15] J Pinnekamp,et al. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. , 2011, Water science and technology : a journal of the International Association on Water Pollution Research.
[16] Paola Verlicchi,et al. Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options , 2010 .
[17] Kurtis Sarafin,et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. , 2006, The Science of the total environment.
[18] R M Mader,et al. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. , 2007, Chemosphere.
[19] D. Barceló,et al. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. , 2006, Talanta.
[20] Y. Perrodin,et al. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. , 2008, The Science of the total environment.
[21] Ji-feng Yang,et al. Occurrence and a screening‐level risk assessment of human pharmaceuticals in the Pearl River system, South China , 2010, Environmental toxicology and chemistry.
[22] Damià Barceló,et al. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.
[23] E. Thurman,et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .
[24] J. Santos,et al. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). , 2007, Environment international.
[25] Francisco Omil,et al. Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. , 2009, Bioresource technology.
[26] A. Fernández-Alba,et al. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. , 2010, Water research.
[27] K Kümmerer,et al. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review. , 2001, Chemosphere.
[28] Kevin V Thomas,et al. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. , 2009, Environment international.
[29] D. Barceló,et al. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. , 2006, Talanta.
[30] Despo Fatta-Kassinos,et al. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research , 2011, Analytical and bioanalytical chemistry.
[31] Karin Treyer,et al. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. , 2011, Water research.
[32] Sun-Kyoung Shin,et al. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. , 2011, Chemosphere.
[33] Ignasi Rodríguez-Roda,et al. Comparison of removal of pharmaceuticals in MBR and activated sludge systems , 2010 .
[34] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[35] T. Albanis,et al. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. , 2010, Journal of hazardous materials.
[36] Martin Schlabach,et al. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. , 2007, Journal of environmental monitoring : JEM.
[37] M. Reinhard,et al. Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects. , 2010, The Science of the total environment.
[38] K. Thomas,et al. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. , 2006, The Science of the total environment.
[39] D. Barceló,et al. Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters. , 2006, Journal of chromatography. A.
[40] Steve Carter,et al. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. , 2010, Water research.